<DOC>
	<DOC>NCT00959816</DOC>
	<brief_summary>The objective of this study is to determine the amount of ABT-614 in the cerebral spinal fluid and blood after administration of a single dose and after administration of daily doses for 14 days in healthy volunteers.</brief_summary>
	<brief_title>A Study to Investigate the Process by Which ABT-614 is Absorbed, Distributed, Metabolized and Eliminated in Humans</brief_title>
	<detailed_description />
	<criteria>Healthy male subjects between 18 and 40 years of age History of bleeding disorders or deep vein thrombosis (DVT) Previous gastrointestinal (GI) surgery or chronic GI disease History of spinal surgery History of significant, chronic low back pain History of frequent headaches</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>September 2010</verification_date>
	<keyword>Volunteers</keyword>
</DOC>